Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
vector
1:46
TCR redirected T cells for cancer therapy
Chiara Bonini
• 1 Apr 2022
1:34
Impact of COVID-19 on the advanced therapies sector
Christian Schneider
• 29 Oct 2021
2:12
Remaining issues in developing advanced therapies
Christian Schneider
• 29 Oct 2021
1:19
Addressing the regulatory barriers advanced therapies face
Christian Schneider
• 29 Oct 2021
1:22
The landscape of cell therapy for solid tumors
Sven Kili
• 5 Oct 2021
3:09
Vector-based therapies for metabolic disorders
Gloria Gonzalez-Aseguinolaza
• 18 May 2021
2:05
Novel oncolytic Ad6 vectors for cancer therapy
Margarita Romanenko
• 13 May 2021
1:14
The need for next-gen AAV vectors
Arun Srivastava
• 17 May 2021
3:49
NextGen & GenX AAV vectors for DMD gene therapy
Arun Srivastava
• 18 May 2021
4:15
Synthetic AAV vectors for gene therapy of hemophilia in children
Arun Srivastava
• 18 May 2021
2:12
The future impact of COVID-19 on the gene therapy sector
Nicole Faust
• 9 Apr 2021